About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNCT01023893

Blood Viscosity, End-Stage Renal Disease, And Mortality (BEAM-1)

Prospective, real-time observational study of hemodialysis patients treated with erythropoiesis-stimulating agents (ESA) to currently recommended Hgb targets. Subjects will be evaluated dynamically fo...

Lead sponsor: ProMetrics, Inc.•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

ProMetrics, Inc.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Age \> 18 years old
•On hemodialysis \> 3 months
•On ESA treatment \> 3 months
•Mean Hgb 11 g/dL - 12 g/dL (based on at least 3 Hgb results during the previous 8 weeks)
•Latest Hgb 10.5 g/dL - 12.5 g/dL (measured within 1 week of study)

Exclusion Criteria

•Inability or unwillingness to provide informed consent
•Large variability in interdialytic weight gain (\>2 kg difference between low and high weight gain over last month)
•More than 1 missed dialysis treatments in past month
•Recent bleeding
•Blood transfusion within 1 month
•Hematologic disease other than anemia
•Active inflammatory disease
•Active infection

Related studies

Continuous Veno-venous Hemodialysis and Continuous Veno-venous Hemodiafiltration on Urea Reduction Rate in Intensive Care Patient

NCT06369064 · Acute Kidney Injury, Continuous Renal Replacement Therapy, and more

Epidemiology and Processes of Care for Renal Replacement Therapy in Acute Kidney Injury in Latin America

NCT07262320 · Dialysis, Critically Ill Acute Kidney Injury, and more

Timing of Renal Replacement Therapy Initiation in Tumor Lysis Syndrome

NCT06889974 · Renal Replacement Therapy for Acute Kidney Injury in ICU

RECRUITINGPhase 2

Effects of Variation of Sodium Dialysate in ICU

NCT03329313 · Acute Kidney Injury, Renal Replacement Therapy

Filter Lifespan in Continuous Renal Replacement Therapy

NCT05450185 · Critically Ill, Continuous Renal Replacement Therapy, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 2, 2009Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment400

Start dateNov 2009

Last updatedDec 2, 2009

Condition

Renal Replacement Therapy

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 2, 2009Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions